2022 Announcements

CLINUVEL.
Posted by CLINUVEL.
January 27, 2022

CLINUVEL Communiqué 1

Happy New Year to all our stakeholders for 2022, a year in...

Read More
CLINUVEL
Posted by CLINUVEL
January 24, 2022

SCENESSE® continued in Germany

CLINUVEL today announced that it has entered a second agreement with the...

Read More
CLINUVEL
Posted by CLINUVEL
January 19, 2022

Change of Director’s Interest Notice

Melbourne, Australia, 19 January 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
January 19, 2022

Notification of Cessation of Securities

Melbourne, Australia, 19 January 2022 ASX: XETRA-DAX: Level 1 ADR: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
January 17, 2022

CLINUVEL completes enrolment in world-first stroke study

CLINUVEL today announced that it has completed enrolment in its world-first study...

Read More
CLINUVEL
Posted by CLINUVEL
January 10, 2022

CLINUVEL’S GROWTH AND EXPANSION - H.C. Wainwright Bioconnect Conference 2022

CLINUVEL's Head of Investor Relations, Malcolm Bull, presents to the H.C. Wainwright...

Read More